We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Sector Composition

Rank Sector Weight
1 Healthcare 29.51%
2 Technology 16.43%
3 Financials 13.12%
4 Communication Services 9.43%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBCP
151
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$7.29M 0.03%
+750,000
New +$7.34M
SLAC
152
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$7.29M 0.03%
+750,000
New +$7.32M
KVSA
153
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$6.92M 0.03%
700,000
+100,000
+17% +$1.02M
NRGV icon
154
Energy Vault
NRGV
$691M
$6.83M 0.03%
+700,000
New +$6.84M
STRE
155
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
$6.81M 0.03%
+700,000
New +$6.84M
TECX
156
Tectonic Therapeutic
TECX
$736M
$6.58M 0.03%
61,667
GTPB
157
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$5.95M 0.02%
+600,000
New +$5.94M
DAVE icon
158
Dave Inc
DAVE
$4.52B
$5.93M 0.02%
+18,750
New +$5.92M
IPVI
159
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
$5.85M 0.02%
+600,000
New +$5.87M
RXRA
160
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
$5.83M 0.02%
+600,000
New +$5.88M
FSRX
161
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$5.82M 0.02%
+600,000
New +$5.88M
KRYS icon
162
Krystal Biotech
KRYS
$10.3B
$5.1M 0.02%
75,000
-550,000
-88% -$38.4M
SRNG
163
DELISTED
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
$4.98M 0.02%
+500,000
New +$5M
HMCO
164
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$4.96M 0.02%
508,900
+100,000
+24% +$990K
TCVA
165
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$4.96M 0.02%
+500,000
New +$5.07M
IMGN
166
DELISTED
Immunogen Inc
IMGN
$4.94M 0.02%
750,000
GSQD
167
DELISTED
G Squared Ascend I Inc.
GSQD
$4.93M 0.02%
+500,000
New +$4.91M
SMRT icon
168
SmartRent
SMRT
$274M
$4.92M 0.02%
400,000
-100,000
-20% -$1.08M
RKTA
169
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
$4.92M 0.02%
+500,000
New +$4.9M
LCA
170
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$4.88M 0.02%
+500,000
New +$4.9M
CLAA
171
DELISTED
Colonnade Acquisition Corp. II
CLAA
$4.88M 0.02%
+500,000
New +$4.9M
HERA
172
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$4.88M 0.02%
+500,000
New +$4.89M
COGT icon
173
Cogent Biosciences
COGT
$6.37B
$4.87M 0.02%
600,000
TIOA
174
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
$4.84M 0.02%
+500,000
New +$4.86M
SCOB
175
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$4.37M 0.02%
+450,000
New +$4.4M

Similar funds

Thomas Steyer's Q2 2021 Portfolio in Review

As of Q2 2021, Thomas Steyer held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thomas Steyer deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Thomas Steyer's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Thomas Steyer's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Thomas Steyer fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Thomas Steyer opened 164 new positions and closed 100 in Q2 2021.
  • Thomas Steyer's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.